Cargando…
Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085113/ https://www.ncbi.nlm.nih.gov/pubmed/27203210 http://dx.doi.org/10.18632/oncotarget.9397 |
_version_ | 1782463505825267712 |
---|---|
author | Jiang, Dingyuan Huang, Xiaoxi Geng, Jing Dong, Run Li, Shuhong Liu, Zheng Wang, Chen Dai, Huaping |
author_facet | Jiang, Dingyuan Huang, Xiaoxi Geng, Jing Dong, Run Li, Shuhong Liu, Zheng Wang, Chen Dai, Huaping |
author_sort | Jiang, Dingyuan |
collection | PubMed |
description | Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we investigated whether repeated challenge with PA induces persistent inflammation leading to sarcoidosis followed by PF in mice. Specifically, C57BL/6 mice were inoculated intraperitoneally and subjected to intratracheal challenge with PA, and then were booster-challenged with either PA or phosphate-buffered saline on day 28. Inflammation, granulomata, and features of fibrosis were evaluated every 7 days until day 70. Complete remission of lung granulomata was apparent on day 42 in the sarcoid-remission group. However, granulomata was present from days 21 to 70 in mice that received PA boosting. Inflammatory cell counts and Th1 cytokine levels in lung lavage fluids were elevated up to day 70. Furthermore, fibrotic changes in the lungs were observed around granulomatous and peribronchovascular regions after PA boosting. Taken together, these findings suggest that development of PF following sarcoidosis may result from continuous PA infection and inflammation. Repeated boosting with PA to induce PF might be a useful model for future studies of sarcoidosis-associated PF. |
format | Online Article Text |
id | pubmed-5085113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-50851132016-10-31 Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes Jiang, Dingyuan Huang, Xiaoxi Geng, Jing Dong, Run Li, Shuhong Liu, Zheng Wang, Chen Dai, Huaping Oncotarget Research Paper: Pathology Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we investigated whether repeated challenge with PA induces persistent inflammation leading to sarcoidosis followed by PF in mice. Specifically, C57BL/6 mice were inoculated intraperitoneally and subjected to intratracheal challenge with PA, and then were booster-challenged with either PA or phosphate-buffered saline on day 28. Inflammation, granulomata, and features of fibrosis were evaluated every 7 days until day 70. Complete remission of lung granulomata was apparent on day 42 in the sarcoid-remission group. However, granulomata was present from days 21 to 70 in mice that received PA boosting. Inflammatory cell counts and Th1 cytokine levels in lung lavage fluids were elevated up to day 70. Furthermore, fibrotic changes in the lungs were observed around granulomatous and peribronchovascular regions after PA boosting. Taken together, these findings suggest that development of PF following sarcoidosis may result from continuous PA infection and inflammation. Repeated boosting with PA to induce PF might be a useful model for future studies of sarcoidosis-associated PF. Impact Journals LLC 2016-05-17 /pmc/articles/PMC5085113/ /pubmed/27203210 http://dx.doi.org/10.18632/oncotarget.9397 Text en Copyright: © 2016 Jiang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper: Pathology Jiang, Dingyuan Huang, Xiaoxi Geng, Jing Dong, Run Li, Shuhong Liu, Zheng Wang, Chen Dai, Huaping Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes |
title | Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
|
title_full | Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
|
title_fullStr | Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
|
title_full_unstemmed | Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
|
title_short | Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
|
title_sort | pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with propionibacterium acnes |
topic | Research Paper: Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085113/ https://www.ncbi.nlm.nih.gov/pubmed/27203210 http://dx.doi.org/10.18632/oncotarget.9397 |
work_keys_str_mv | AT jiangdingyuan pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT huangxiaoxi pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT gengjing pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT dongrun pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT lishuhong pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT liuzheng pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT wangchen pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes AT daihuaping pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes |